Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin versus terazosin for voiding dysfunction in women
IRCT20200825048515N85Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in functional bladder outlet obstruction and Micturition disorder comparing Tamsulosin with Terazosin (2 arms). Primary endpoints: Clinical urinary symptoms and Bladder strip index. Started Aug 2025; status: completed.
02
Drugs
tamsulosinterazosin
03
Conditions
functional bladder outlet obstructionMicturition disorder
Beyond the preview
Go deeper on IRCT20200825048515N85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N85.